Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Retained Earnings came in at $3.4 million in Q4 2025, up 48.84% YoY from $2.3 million in Q4 2024, and up 68.83% on a QoQ basis from $2.0 million in Q2 2025.
Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Retained Earnings data on file, last reported at $3.4 million in Q4 2025.
- Quarterly Retained Earnings rose 48.84% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 48.84% YoY) and the FY2025 annual result came in at $2.0 million, up 102.62% from the prior year.
- Retained Earnings improved to $3.4 million in Q4 2025, from $2.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.4 million in Q4 2025 to a low of -$75.9 million in Q2 2024.
- A 5-year average of -$9.2 million and a median of $2.1 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 129.72% — and 2024, when it slumped 3183.99%.
- Tracing KZIA's Retained Earnings over 5 years: stood at $983709.8 in 2021, then surged by 129.72% to $2.3 million in 2022, then rose by 15.63% to $2.6 million in 2023, then retreated by 13.82% to $2.3 million in 2024, then soared by 48.84% to $3.4 million in 2025.
- The last three Retained Earnings figures came in at $3.4 million (Q4 2025), $2.0 million (Q2 2025), and $2.3 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | -95.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.35 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Jun 30, 2024 | -75.87 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Dec 31, 2021 | 983,709.84 |
| Jun 30, 2021 | -34.04 Mn |
| Dec 31, 2020 | 764,337.76 |
| Jun 30, 2020 | -23.72 Mn |
| Dec 31, 2019 | 1.53 Mn |
| Jun 30, 2019 | -17.48 Mn |
| Dec 31, 2018 | 1.41 Mn |
| Jun 30, 2018 | -11.08 Mn |
| Jun 30, 2017 | -128.43 Mn |
| Dec 31, 2016 | 1.53 Mn |
| Jun 30, 2016 | 1.44 Mn |
| Dec 31, 2015 | 712,493.22 |